A6X Stock Overview
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
aXichem AB Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr0.096 |
52 Week High | kr1.25 |
52 Week Low | kr0.088 |
Beta | 0.13 |
1 Month Change | -14.69% |
3 Month Change | -60.17% |
1 Year Change | -83.38% |
3 Year Change | -97.24% |
5 Year Change | -98.54% |
Change since IPO | -97.93% |
Recent News & Updates
Recent updates
Shareholder Returns
A6X | DE Chemicals | DE Market | |
---|---|---|---|
7D | -3.6% | 5.6% | 1.3% |
1Y | -83.4% | 8.0% | 6.4% |
Return vs Industry: A6X underperformed the German Chemicals industry which returned 8% over the past year.
Return vs Market: A6X underperformed the German Market which returned 6.4% over the past year.
Price Volatility
A6X volatility | |
---|---|
A6X Average Weekly Movement | 23.8% |
Chemicals Industry Average Movement | 4.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: A6X's share price has been volatile over the past 3 months.
Volatility Over Time: A6X's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 7 | Torsten Helsing | https://www.axichem.com |
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.
aXichem AB Fundamentals Summary
A6X fundamental statistics | |
---|---|
Market cap | €2.82m |
Earnings (TTM) | -€1.82m |
Revenue (TTM) | €158.36k |
17.8x
P/S Ratio-1.5x
P/E RatioIs A6X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A6X income statement (TTM) | |
---|---|
Revenue | kr1.81m |
Cost of Revenue | kr400.00k |
Gross Profit | kr1.41m |
Other Expenses | kr22.22m |
Earnings | -kr20.81m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.97 |
Gross Margin | 77.89% |
Net Profit Margin | -1,150.41% |
Debt/Equity Ratio | 21.2% |
How did A6X perform over the long term?
See historical performance and comparison